Data Bridge Market Research analyses that the viral testing market which is expected to grow at a healthy CAGR during the forecast period 2022 to 2029

The method of finding viruses in a sample is known as viral testing. Viruses can be found in a variety of areas, including surfaces and the environment. Testing can assist in locating viruses that could spread disease. A viral test is a diagnostic tool used to determine whether or not a person has been infected with a virus.

Viral Testing Market Analysis and Size:

World Health Organization (WHO) estimates that in 2022, new cases of COVID-19 worldwide increased by 5%. By offering diagnostic tests and kits, the market participants seized the chance to diversify their product offerings and increase their market share significantly. Stanford Medicine processed its one millionth COVID-19 PCR test in February 2022, according to an article titled "At clinical virology lab, 1 million COVID-19 tests and counting" that was published in February 2022.

Get More Info: https://www.databridgemarketresearch.com/reports/global-viral-testing-market

Some of the major players operating in the viral testing market are:

• F. Hoffmann-La Roche Ltd (Switzerland)
• Agilent Technologies, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• QIAGEN (Germany)
• Lonza (Switzerland)
• Sigma-Aldrich Co. (U.S.)
• Wuxi AppTec (China)
• Merck & Co. Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• General Electric (U.S.)

Competitive Landscape and Viral Testing Market Share Analysis

The viral testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to viral testing market.

Recent Development

•In May 2022, QuantuMDx Group Limited announced the release of Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a novel respiratory panel test. Rapid point-of-care testing is offered to customers through the Q-POC platform and its multiplex capabilities in both clinical and non-clinical contexts.
•In January 2022, A brand-new, extremely sensitive SARS-CoV-2 Rapid Antigen Test -AQ+ Covid-19 Ag Rapid Test for usage by professionals was introduced by InTec. The AQ+ Covid-19 Ag Rapid Test is designed to be used by laypeople or medical professionals to quickly and easily detect Covid-19.

More Links:

https://dbmr232343.blogspot.com/2023/06/athletes-foot-drugs-market-industry.html

https://dbmr232343.blogspot.com/2023/06/pediatric-mechanical-heart-valve-market.html

https://dbmr232343.blogspot.com/2023/06/computerized-physician-order-entry-cpoe.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.